Wijaya Natalia, Ong-Ramos Celeste
Department of Internal Medicine, De Los Santos Medical Center, Quezon City, Philippines.
J ASEAN Fed Endocr Soc. 2019;34(1):99-102. doi: 10.15605/jafes.034.01.16. Epub 2019 May 21.
A 34-year-old female Filipino with Graves' disease on methimazole came in due to fever, sore throat and jaundice. She was initially diagnosed with methimazole-induced agranulocytosis and drug-induced liver injury. She was treated with intravenous broad-spectrum antibiotic and granulocyte colony stimulating factor. On day 4 of admission, she developed pancytopenia and was managed as methimazole-induced aplastic anemia. She was started on steroid therapy and received 1 unit of packed red blood cell. The jaundice also increased, hence, she was given ursodeoxycholic acid. On day 9 of admission, with the consideration of "lineage steal phenomenon," biopsy was done and eltrombopag was started. Patient was discharged stable at 12th hospital day. This case presents 3 rare life-threatening complications of methimazole namely: agranulocytosis, aplastic anemia and hepatitis.
一名34岁患格雷夫斯病且正在服用甲巯咪唑的菲律宾女性,因发热、咽痛和黄疸前来就诊。她最初被诊断为甲巯咪唑引起的粒细胞缺乏症和药物性肝损伤。她接受了静脉注射广谱抗生素和粒细胞集落刺激因子治疗。入院第4天,她出现全血细胞减少,并被诊断为甲巯咪唑引起的再生障碍性贫血。她开始接受类固醇治疗,并输注了1单位浓缩红细胞。黄疸也有所加重,因此,给她使用了熊去氧胆酸。入院第9天,考虑到“谱系窃取现象”,进行了活检并开始使用艾曲泊帕。患者在住院第12天病情稳定出院。该病例呈现了甲巯咪唑3种罕见的危及生命的并发症,即:粒细胞缺乏症、再生障碍性贫血和肝炎。